Evidence map›Paper›PMID 40312382›Full record

ArticleMalaria journal2025

Field evaluation of the Bioline Malaria Ag P.f/Pan rapid diagnostic test: causes of microscopy discordance and performance in Uganda.

Kisakye Diana Kabbale, Bienvenu Nsengimaana, Francis D Semakuba, Brian A Kagurusi, Caroline Mwubaha, Innocent Wiringilimaana, Thomas Katairo, Shahiid Kiyaga, Monica Mbabazi, Samuel Gonahasa and 15 more

Abstract read
In one paragraph

Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Kisakye Diana KabbaleInfectious Diseases Research Collaboration, Kampala, Uganda. dikisakye@gmail.com.
Bienvenu NsengimaanaInfectious Diseases Research Collaboration, Kampala, Uganda.
Francis D SemakubaInfectious Diseases Research Collaboration, Kampala, Uganda.
Brian A KagurusiInfectious Diseases Research Collaboration, Kampala, Uganda.
Caroline MwubahaInfectious Diseases Research Collaboration, Kampala, Uganda.
Innocent WiringilimaanaInfectious Diseases Research Collaboration, Kampala, Uganda.
Thomas KatairoInfectious Diseases Research Collaboration, Kampala, Uganda.
Shahiid KiyagaInfectious Diseases Research Collaboration, Kampala, Uganda.
Monica MbabaziInfectious Diseases Research Collaboration, Kampala, Uganda.
Samuel GonahasaInfectious Diseases Research Collaboration, Kampala, Uganda.
Moses R KamyaInfectious Diseases Research Collaboration, Kampala, Uganda.
Stephen TukwasibweInfectious Diseases Research Collaboration, Kampala, Uganda.
Sam L NsobyaInfectious Diseases Research Collaboration, Kampala, Uganda.
Victor AsuaInfectious Diseases Research Collaboration, Kampala, Uganda.
Daudi JjingoAfrican Center of Excellence in Bioinformatics and Data Intensive Sciences, Makerere University, Kampala, Uganda.
Bosco AgabaNational Malaria Control Division, Ministry of Health, Kampala, Uganda.
Catherine Maiteki-SebuguziNational Malaria Control Division, Ministry of Health, Kampala, Uganda.
Jimmy OpigoNational Malaria Control Division, Ministry of Health, Kampala, Uganda.
Kylie HiltonUniversity of California, Berkeley, USA.
Sarah G StaedkeLiverpool School of Tropical Medicine, Liverpool, UK.
Grant DorseyDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Melissa D ConradDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Bryan GreenhouseDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Isaac SsewanyanaInfectious Diseases Research Collaboration, Kampala, Uganda.
Jessica BriggsDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.

Funding

Transmission ProjectU19AI089674 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHEW G DORSEY, MOSES Robert KAMYA · 2010 to 2026
$29.3M
Mentoring translational scientists in international infectious disease researchK24AI144048 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Bryan R Greenhouse · 2019 to 2026
$1.6M
NURTURING GENOMICS AND BIOINFORMATICS RESEARCH CAPACITY IN AFRICA (BRecA)U2RTW010672 · FIC · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI JJINGO, DAUDI, KATEETE, DAVID PATRICK · 2017 to 2022
$1.3M
Improving the accuracy of malaria surveillance with serology and parasite genetic dataK23AI166009 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jessica Briggs · 2022 to 2026
$955k
FIC NIH HHS U2RTW010672Gates Foundation INV-035751NIAID NIH HHS K23 AI166009NIAID NIH HHS K24 AI144048NIAID NIH HHS U19 AI089674NIH HHS U19AI089674NIH-NIAID K23AI166009NIH-NIAID K24AI144048
6 · The paper itself

Abstract

backgroundHistidine Rich Protein 2 (HRP2)/pan-Lactate Dehydrogenase (pLDH) combination rapid diagnostic tests (RDTs) may address the shortcomings of RDTs that detect HRP2 alone. However, the relative contribution of the possible causes of discordant results (RDT-negative and microscopy-positive) and performance in field settings across Uganda are poorly quantified.

methodsThis study utilized samples from two cross-sectional surveys conducted in 32 districts at 64 sites across Uganda between November 2021 and March 2023 that enrolled 6354 febrile participants  ≥ two years of age. Discordant samples (negative by HRP2/pLDH RDT and positive by microscopy) underwent quantitative PCR (qPCR) to detect and quantify parasitaemia. Those confirmed to be positive for Plasmodium falciparum at > 1 parasites/microlitre (p/µL) were tested for pfhrp2 and pfhrp3 deletions using digital PCR. Those that were negative or had P. falciparum detected at ≤ 1 p/µL underwent Plasmodium species testing using nested PCR. The performance of the Bioline Malaria Ag P.f/Pan combination RDT was evaluated by comparison with microscopy and qPCR.

resultsThere were 166 (8.4%) discordant samples out of 1988 microscopy positive samples. Of these, 90/166 (54.2%) were confirmed to contain P. falciparum at levels > 1 p/µL, whereas 76/166 (45.8%) were negative or had P. falciparum levels ≤ 1 p/µL. Only one P. falciparum positive sample was confirmed to have a deletion in pfhrp3. The primary reasons for RDT-negative, microscopy-positive discordance in samples testing negative for P. falciparum by PCR were non-falciparum species (37/76, 48.7%) or false positives by microscopy (31/76, 40.8%). The sensitivity of the Bioline Malaria Ag P.f/Pan combination RDT was high (> 91%) using either microscopy or qPCR as the gold standard. However, specificity was low (56.7%) when microscopy was used as the gold standard; it improved to 64.0% when qPCR was used as the gold standard.

conclusionThe Bioline Malaria Ag P.f/Pan combination RDT was found to be highly sensitive in Uganda and reliable for ruling out malaria. False negative RDT results were primarily due to low density P. falciparum infections, non-falciparum infections, or incorrect microscopy results. In contrast, false positive RDT results were common, most likely due to persistent HRP2 antigenaemia in this high transmission setting though causes of false positive RDTs were not investigated. The low specificity of HRP2-based RDTs may result in overuse of anti-malarial drugs and missed diagnoses of non-malarial febrile illnesses.

Indexed as

Antigens, ProtozoanDiagnostic Tests, RoutineMalaria, FalciparumMicroscopyPlasmodium falciparumProtozoan ProteinsAdolescentAdultChildChild, PreschoolCross-Sectional StudiesFemaleHumansMaleMiddle AgedRapid Diagnostic TestsAntigens, ProtozoanHRP-2 antigen, Plasmodium falciparumProtozoan ProteinsDiscordanceHRP2/pLDH combination rapid diagnostic testMalariaPerformancePfhrp2Pfhrp3Plasmodium falciparumSensitivitySpecificity

Identifiers

PMID40312382
PMCPMC12044711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.